Leslie C C, McCormick-Shannon K, Shannon J M, Garrick B, Damm D, Abraham J A, Mason R J
Department of Pediatrics and Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
Am J Respir Cell Mol Biol. 1997 Apr;16(4):379-87. doi: 10.1165/ajrcmb.16.4.9115748.
Alveolar type II cells proliferate and differentiate into type I epithelial cells to restore the alveolar epithelium after lung injury. Since mitogens that bind the epidermal growth factor (EGF), EGF, receptor and transforming growth factor alpha (TGF alpha) have been shown to stimulate type II cell proliferation, studies were undertaken to determine whether the recently described protein, heparin-binding EGF-like growth factor (HB-EGF), was a mitogen for rat alveolar type II cells in primary culture. In addition, since HB-EGF is produced by macrophages, it was of interest to determine whether mitogenic activity for type II cells present in macrophage conditioned medium was due to HB-EGF. Rat and human recombinant HB-EGF stimulated thymidine incorporation into rat type II cells in a concentration-dependent manner up to 10-50 ng/ml then became inhibitory. The nuclear labeling index of type II cells increased from 2% to 16% with 10 ng/ml HB-EGF. However, HB-EGF induced only a small increase in cell number after 48 h and did not support low-density proliferation of alveolar type II cells. Conditioned medium from the human monocytic cell line, U937, stimulated type II cell DNA synthesis, and stimulatory activity could be partially purified by S-sepharose and heparin-sepharose chromatography. The growth-promoting activity from U937 cells that bound to heparin-sepharose was inhibited by a neutralizing antibody to human HB-EGF. Immunoblot analysis of active fractions also verified the presence of HB-EGF. However, the neutralizing antibody to rat HB-EGF did not inhibit mitogenic activity for type II cells found in rat bronchoalveolar lavage fluid. HB-EGF mRNA was found to be expressed in human alveolar macrophages to similar levels as differentiated U937 cells but was not detected in rat alveolar macrophages by Northern analysis of total mRNA. There was no difference in the level of HB-EGF mRNA expression in human alveolar macrophages from patients with interstitial lung disease compared with macrophages from normal subjects. The results demonstrate that HB-EGF is a mitogen for rat alveolar type II cells but appears to show species-specific differences with regard to its production by macrophages. Leslie, C. C., K. McCormick-Shannon, J. M. Shannon, B. Garrick, D. Damm, J. A. Abraham, and R. J. Mason. 1997. Heparin-binding EGF-like growth factor is a mitogen for rat alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 16:379-387.
肺损伤后,Ⅱ型肺泡细胞增殖并分化为Ⅰ型上皮细胞以修复肺泡上皮。由于已证明结合表皮生长因子(EGF)、EGF受体和转化生长因子α(TGFα)的促有丝分裂原可刺激Ⅱ型细胞增殖,因此开展了研究以确定最近描述的蛋白——肝素结合表皮生长因子样生长因子(HB-EGF)是否是原代培养大鼠Ⅱ型肺泡细胞的促有丝分裂原。此外,由于HB-EGF由巨噬细胞产生,因此确定巨噬细胞条件培养基中存在的对Ⅱ型细胞的促有丝分裂活性是否归因于HB-EGF很有意义。大鼠和人重组HB-EGF以浓度依赖方式刺激胸苷掺入大鼠Ⅱ型细胞,最高可达10 - 50 ng/ml,然后变为抑制作用。10 ng/ml HB-EGF使Ⅱ型细胞的核标记指数从2%增加到16%。然而,48小时后HB-EGF仅使细胞数量略有增加,并且不支持Ⅱ型肺泡细胞的低密度增殖。人单核细胞系U937的条件培养基刺激Ⅱ型细胞DNA合成,刺激活性可通过S-琼脂糖凝胶和肝素-琼脂糖凝胶色谱法部分纯化。与肝素-琼脂糖凝胶结合的U937细胞的促生长活性被抗人HB-EGF的中和抗体抑制。活性组分的免疫印迹分析也证实了HB-EGF的存在。然而,抗大鼠HB-EGF的中和抗体不抑制大鼠支气管肺泡灌洗液中发现的对Ⅱ型细胞的促有丝分裂活性。通过对总mRNA的Northern分析发现,HB-EGF mRNA在人肺泡巨噬细胞中的表达水平与分化的U937细胞相似,但在大鼠肺泡巨噬细胞中未检测到。与正常受试者的巨噬细胞相比,间质性肺疾病患者的人肺泡巨噬细胞中HB-EGF mRNA表达水平没有差异。结果表明,HB-EGF是大鼠Ⅱ型肺泡细胞的促有丝分裂原,但在巨噬细胞产生方面似乎存在物种特异性差异。莱斯利,C.C.,K.麦科米克-香农,J.M.香农,B.加里克,D.达姆,J.A.亚伯拉罕,和R.J.梅森。1997年。肝素结合表皮生长因子样生长因子是大鼠Ⅱ型肺泡细胞的促有丝分裂原。《美国呼吸细胞与分子生物学杂志》16:379 - 387。